Compare LEXX & TCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LEXX | TCBS |
|---|---|---|
| Founded | 2004 | 1934 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.5M | 47.7M |
| IPO Year | N/A | N/A |
| Metric | LEXX | TCBS |
|---|---|---|
| Price | $0.52 | $17.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 2.8K |
| Earning Date | 01-13-2026 | 11-07-2025 |
| Dividend Yield | N/A | ★ 1.15% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.87 |
| Revenue | $705,923.00 | ★ $15,268,000.00 |
| Revenue This Year | $13.35 | N/A |
| Revenue Next Year | $78.83 | N/A |
| P/E Ratio | ★ N/A | $20.10 |
| Revenue Growth | 52.05 | ★ 54.88 |
| 52 Week Low | $0.46 | $15.00 |
| 52 Week High | $2.43 | $20.00 |
| Indicator | LEXX | TCBS |
|---|---|---|
| Relative Strength Index (RSI) | 30.32 | 64.85 |
| Support Level | $0.46 | $17.19 |
| Resistance Level | $0.58 | $20.00 |
| Average True Range (ATR) | 0.12 | 0.92 |
| MACD | -0.05 | 0.15 |
| Stochastic Oscillator | 4.18 | 40.23 |
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.